GDF15 ‐Treated iPSC ‐ MSC ‐Derived Exosomes Alleviate Fibrosis Post‐Myocardial Infarction via Repression of the MFAP4 / ERK /Drp1 Axis
The FASEB Journal · 15.03.2026 · 40 (5)
DOI: 10.1096/fj.202504078r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 25.02.2026. Verfasst von Jie Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangz…. Hauptthemen laut MEDLINE: Exosomes, Myocardial Infarction, Mesenchymal Stem Cells, Growth Differentiation Factor 15. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: the National Key R&D Program of China-Intergovernmental Key Projects, the National Natural Science Grant of China, Natural Science Foundation for Distinguished Scholars of Guangdong Province.
Abstract (Originalsprache)
Cardiac fibrosis post‐myocardial infarction (MI) induces adverse cardiac remodeling, ultimately resulting in heart failure. Exosomes (EXOs) derived from mesenchymal stem cells (MSCs) have emerged as potent modulators of post‐infarction remodeling, capable of limiting fibrotic responses. Our previous study showed that growth differentiation factor 15 as pretreatment promoted the protective effects of MSCs against myocardial fibrosis post‐MI via paracrine actions. We investigated whether exosomes derived from GDF15‐treated iPSC‐MSCs (GDF15‐iPSC‐MSC‐EXOs) could alleviate post‐MI fibrosis and further explored the mechanistic pathways underlying their effects. In a mouse model of MI, EXOs released from iPSC‐MSCs and GDF15‐treated iPSC‐MSCs were collected from culture supernatants and subsequently administered intramuscularly around the infarct area. Cardiac fibrosis was assessed by Masson's trichrome staining. A collagen synthesis model in mouse cardiac fibroblasts (mCFs) was established by transforming growth factor‐β1 (TGF‐β1) treatment in vitro. The mitochondrial morphology of mCFs under TGF‐β1 stimulation was evaluated by Mitotracker staining. Delivery of EXOs from GDF15‐treated iPSC‐MSCs resulted in less fibrotic remodeling and better ventricular function after MI than exosomes from untreated cells. In TGF‐β1‐stimulated fibroblasts, both exosome types reduced fibrosis markers by preventing mitochondrial fission, with GDF15‐iPSC‐MSC‐EXOs affording stronger protection. These effects were partly attenuated in the presence of the mitochondrial fission activator FCCP. Mechanistically, GDF15, which is rich in GDF15‐iPSC‐MSC‐EXOs, inhibited TGF‐β1‐induced mCF activation via repression of the MFAP4/ERK/Drp1 pathway through a direct physical interaction with MFAP4. GDF15 conditioning strengthened the capacity of iPSC‐MSC‐derived exosomes to mitigate cardiac fibrosis following MI via inhibition of mitochondrial fragmentation in CFs by repressing the MFAP4/ERK/Drp1 pathway. GDF15 pretreatment is a novel strategy to enhance the cardioprotection of iPSC‐MSC‐EXOs against cardiac fibrosis post‐MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Guangdong…
- Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
ORCID-Profile: Bei Hu, Xiaoting Liang, Yuelin Zhang
Förderung
- the National Key R&D Program of China-Intergovernmental Key Projects
- the National Natural Science Grant of China
- Natural Science Foundation for Distinguished Scholars of Guangdong Province
- Nature Science Foundation of Guangdong Province
- Foundation of Distinguished Scholars of Guangdong Provincial People's Hospital
- the Natural Science Foundation of Shanghai
Zitieren
APA
Qiu, J., Han, Q., Shen, Y., Yang, Q., Li, Z., Hong, Y., Zhao, J., Lin, F., Ma, K., Hu, B., Liang, X., & Zhang, Y. (2026). GDF15 ‐Treated iPSC ‐ MSC ‐Derived Exosomes Alleviate Fibrosis Post‐Myocardial Infarction via Repression of the MFAP4 / ERK /Drp1 Axis. The FASEB Journal, 40(5). https://doi.org/10.1096/fj.202504078r
Vancouver
Qiu J, Han Q, Shen Y, Yang Q, Li Z, Hong Y, et al. GDF15 ‐Treated iPSC ‐ MSC ‐Derived Exosomes Alleviate Fibrosis Post‐Myocardial Infarction via Repression of the MFAP4 / ERK /Drp1 Axis. The FASEB Journal. 2026;40(5). doi:10.1096/fj.202504078r
BibTeX
@article{Qiu2026,
author = {Qiu, Jie and Han, Qian and Shen, Ying and Yang, Qi and Li, Ziqi and Hong, Yimei and Zhao, Junxiu and Lin, Fang and Ma, Kexin and Hu, Bei and Liang, Xiaoting and Zhang, Yuelin},
title = {GDF15 ‐Treated iPSC ‐ MSC ‐Derived Exosomes Alleviate Fibrosis Post‐Myocardial Infarction via Repression of the MFAP4 / ERK /Drp1 Axis},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {5},
doi = {10.1096/fj.202504078r}
}
EUVIMED